
A Shot at Regeneration
In this “marquee” article in Scientific American, Kevin Strange, Ph.D., and Viravuth Yin, Ph.D., write about the discovery of MSI-1436, a regenerative medicine drug candidate to regenerate heart muscle tissue after a heart attack. Strange is the co-founder, president and CEO of Novo Biosciences and the former president of the MDI Biological Laboratory; Yin is the co-founder and chief scientific officer of Novo and an associate professor at the MDI Biological Laboratory.